CI
NVS icon

Conning Inc’s Novartis NVS Stock Holding History

Conning Inc’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,696
Closed -$577K – 514
2019
Q1 		$577K Buy
+6,696
New +$538K 0.02% 322
2018
Q4 		– Sell
-6,331
Closed -$489K – 548
2018
Q3 		$489K Hold
6,331
– – 0.01% 384
2018
Q2 		$429K Sell
6,331
-757
-11% -$52.2K 0.01% 423
2018
Q1 		$513K Sell
7,088
-285
-4% -$21.7K 0.02% 390
2017
Q4 		$555K Sell
7,373
-2,152
-23% -$162K 0.02% 392
2017
Q3 		$733K Buy
9,525
+5,440
+133% +$411K 0.02% 321
2017
Q2 		$306K Sell
4,085
-83
-2% -$5.88K 0.01% 485
2017
Q1 		$277K Buy
4,168
+753
+22% +$50.2K 0.01% 518
2016
Q4 		$223K Buy
+3,415
New +$222K 0.01% 546
2014
Q2 		– Sell
-2,790
Closed -$213K – 574
2014
Q1 		$213K Hold
2,790
– – 0.01% 540
2013
Q4 		$201K Buy
+2,790
New +$194K 0.01% 522

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Conning Inc's NVS Position: Q2 2019 in Review

Conning Inc sold out of Novartis (NVS) in Q2 2019, closing a stake of 6,696 shares — an estimated $577K sold.

Conning Inc first reported a position in NVS in Q4 2013 and held it in 11 quarters. The position peaked at $733K in Q3 2017. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

  • Conning Inc reported no remaining Novartis position as of Q2 2019 after selling out during the quarter.
  • Conning Inc sold 6,696 Novartis shares in Q2 2019, an estimated $577K.
  • Conning Inc first reported a position in Novartis in Q4 2013 and held it in 11 quarters.
  • Conning Inc's Novartis position peaked at $733K in Q3 2017.
  • 1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Conning Inc's 13F filing for Q2 2019, filed 25 Jul 2019.